|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income before noncontrolling interest | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Net amortization and accretion of investments | |||||
| Net amortization of deferred loan costs | |||||
| Provision (release of allowance) for credit losses | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Stock-based compensation related to equity method investments | |||||
| Loans originated for sale | |||||
| Proceeds of loans held-for-sale sold | |||||
| Holding gain on equity securities | |||||
| Gain on sale of equity securities | |||||
| Loss on sale of equity securities | |||||
| Gain on sale of loans, net | |||||
| Loss (gain) on sale of available-for-sale securities, net | |||||
| (Gain) loss on sale of equity securities, net | |||||
| Gain on sale of loans held-for-sale | |||||
| Loss (gain) on sale of loans held for investment | |||||
| Gain on sale of discontinued operations | |||||
| (Gain) loss on divestiture activity | |||||
| Loss (gain) on sale of other real estate owned | |||||
| Gain on sale of assets | |||||
| Income on bank-owned life insurance | |||||
| Deferred income taxes | |||||
| Equity method investments (income) loss | |||||
| Equity method investment gain | |||||
| Return on equity method investments | |||||
| Changes in other assets | |||||
| Changes in other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Purchases of available-for-sale investment securities | |||||
| Maturities/paydowns of available-for-sale investment securities | |||||
| Sales of available-for-sale investment securities | |||||
| Purchases of premises and equipment | |||||
| Disposals of premises and equipment | |||||
| Net proceeds from sale of assets | |||||
| Net change in loans | |||||
| Proceeds of loans held for investment sold | |||||
| Purchases of restricted bank stock | |||||
| Redemptions of restricted bank stock | |||||
| Proceeds from maturities of certificates of deposit with banks | |||||
| Proceeds from sale of other real estate owned | |||||
| Purchase of bank-owned life insurance | |||||
| Proceeds from the surrender of bank-owned life insurance | |||||
| Investment in equity method investments | |||||
| Proceeds from sale of equity securities | |||||
| Net cash transferred for banking center sale | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Purchase of equity securities | |||||
| Proceeds from sales of equity securities | |||||
| Net cash transferred for sale of discontinued operations | |||||
| Proceeds (cash transferred) from divestiture activity, net | |||||
| Net cash (used in) provided by investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Net change in deposits | |||||
| Net change in repurchase agreements | |||||
| Net change in FHLB and other borrowings | |||||
| Issuance of subordinated debt | |||||
| Issuance of senior term loan | |||||
| Payment of senior debt issuance costs | |||||
| Subordinated Debt | |||||
| Senior Loans | |||||
| Principal payments on senior term loan | |||||
| Preferred stock redemption | |||||
| Common stock repurchased | |||||
| Common stock options exercised | |||||
| Withholding cash issued in lieu of restricted stock | |||||
| Cash dividends paid on common stock | |||||
| Cash dividends paid on preferred stock | |||||
| Redemption of noncontrolling interest | |||||
| Issuance of subsidiary membership units | |||||
| Stock purchase from noncontrolling interest | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Cash payments for: | |||||
| Interest on deposits, repurchase agreements and borrowings | |||||
| Income taxes | |||||
| Assets acquired in business combination, net of cash acquired | |||||
| Liabilities assumed in business combination | |||||
| Supplemental disclosure of cash flow information: | |||||
| Fair value of noncontrolling interests at acquisition date | |||||
| Loans transferred to other real estate owned | |||||
| Change in unrealized holding gains (losses) on securities available-for-sale | |||||
| Restricted stock units vested | |||||
| Tax withholding obligations on restricted stock units issued | |||||
| Creation of servicing assets from loan sales | |||||
| Loans transferred to loans held-for-sale | |||||
| Common stock issued related to acquisitions | |||||
| Impact of adopting ASC 326, net of tax | |||||
| Creation of right-of-use asset | |||||
| Creation of lease liability | |||||
| Receivable from loan sale | |||||
Loading...